About two out of three patients with major depressive disorder have unresolved symptoms following first-line antidepressant treatment,1 but the addition of an augmentation therapy might be one strategy to help address this unmet need. Joining Dr. Charles Turck to discuss outcomes for partial and non-responders is Dr. Rakesh Jain, Clinical Professor in the Department of Psychiatry at Texas Tech University School of Medicine at the Permian Basin.
- Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. doi:10.1176/appi.ajp.163.1.28
January 2024 US.UNB.X.23.00140